Medical Disclaimer This content is for educational and informational purposes only and is not medical advice
Finally, I highlight new pharmacological developments, including oral agents, and discuss important questions regarding maintenance therapy
Considering how weight loss is known to reduce ORC rates, Wolff-Sagy conducted an analysis that simulates the incidence of ORC if those taking GLP-1 drugs lost the same amount of weight as BMS patients
This essential contribution of endogenously produced GLP-1 to drug reward is, however, suggested by Tuesta et al
The methodological robustness of the study, and consistency with recent literature support that use of GLP-1 RA does not appear to be associated with an increased risk of suicide or suicide attempts
Those who are pregnant or breastfeeding , as the safety of these medications in pregnancy has not been established